Tvardi director granted 6,000 stock options
Tvardi Therapeutics director Sujal Shah received a stock option grant for 6,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tvardi Therapeutics director Sujal Shah received a stock option grant for 6,000 shares of common stock. The option has an exercise price of $2.78 per share and expires on June 8, 2036. All 6,000 underlying shares will vest on the earlier of June 9, 2027 or the company’s next annual stockholder meeting, assuming he remains in continuous service.
Insider Trade Summary
Grant/Award: 6,000 shares
Grant/Award
1 txn
Insider
Shah Sujal
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 6,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares underlying the option shall vest on the earlier of June 9, 2027 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Option grant size: 6,000 options
Exercise price: $2.78 per share
Post-transaction derivative holdings: 6,000 options
+2 more
5 metrics
Option grant size
6,000 options
Stock Option (right to buy) granted to director
Exercise price
$2.78 per share
Exercise price of granted stock options
Post-transaction derivative holdings
6,000 options
Total options held after grant
Expiration date
June 8, 2036
Option term end date
Vesting date trigger
June 9, 2027 or next annual meeting
100% vesting on earlier of these dates, with continuous service
Key Terms
Stock Option (right to buy), exercise price, expiration date, continuous service, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "2.7800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-08T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
annual meeting of stockholders financial
"the Issuer's next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tvardi Therapeutics (TVRD) report for Sujal Shah?
Tvardi Therapeutics reported that director Sujal Shah received a grant of stock options for 6,000 shares of common stock. These options were awarded as compensation, not purchased on the open market, and increase his derivative holdings in the company.
What is the exercise price of Sujal Shah’s Tvardi Therapeutics stock options?
The granted stock options have an exercise price of $2.78 per share. This is the fixed price at which he can buy Tvardi Therapeutics common shares if the options vest and he chooses to exercise them before expiration.
When do Sujal Shah’s Tvardi Therapeutics options vest?
All 6,000 shares underlying the options vest 100% on the earlier of June 9, 2027 or Tvardi Therapeutics’ next annual stockholder meeting. Vesting is conditioned on his continuous service with the company through the applicable vesting date.
When do Sujal Shah’s Tvardi Therapeutics stock options expire?
The stock options granted to Sujal Shah expire on June 8, 2036. After this expiration date, any unexercised options become worthless, so he must exercise vested options before then to acquire Tvardi Therapeutics common shares.
How many Tvardi Therapeutics options does Sujal Shah hold after this Form 4 transaction?
Following this transaction, Sujal Shah holds 6,000 stock options directly. These options each relate to one share of Tvardi Therapeutics common stock, giving him the right, but not the obligation, to purchase those shares if they vest and he exercises.
AI-generated analysis. How Rhea-AI works. Not financial advice.
